Combining a CD40L-Binding Protein (VIB4920) with a TNF alpha Inhibitor for the Treatment of Inadequately Controlled Rheumatoid Arthritis
Clinical Trial Grant
Administered By
Medicine, Rheumatology and Immunology
Awarded By
Benaroya Research Institute at Virginia Mason
Start Date
February 1, 2022
End Date
January 31, 2026
Administered By
Medicine, Rheumatology and Immunology
Awarded By
Benaroya Research Institute at Virginia Mason
Start Date
February 1, 2022
End Date
January 31, 2026